How Much Weight Can Be Lost on Wegovy?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in medications like Wegovy, has demonstrated significant weight loss effects in large clinical studies. Most patients taking semaglutide lose between 10% and 22% of their starting body weight, though individual results depend on dose escalation, diet consistency, and metabolic factors. Understanding realistic expectations helps you set achievable goals for your weight loss journey.

Average Weight Loss Results from Semaglutide Trials

The STEP trials, which tested semaglutide for chronic weight management, enrolled over 4,500 adults with obesity or overweight and comorbidities. Participants receiving the highest dose (2.4 mg weekly) lost an average of 22.5% of their body weight over 68 weeks—roughly 50 pounds for someone starting at 220 pounds. The lowest effective dose (0.5 mg) produced approximately 5-8% body weight reduction, while intermediate doses (1.7 mg and 2.4 mg) showed progressively stronger effects.

Weight loss typically accelerates during the first 12 weeks as doses increase, then plateaus around week 20-24. Most patients experience the majority of their loss in the first 6 months of treatment. After 68 weeks of active treatment, roughly 80% of participants maintained or continued losing weight, suggesting that semaglutide's appetite-suppressing effects remain consistent over time.

How Your Individual Results May Differ

Body composition, baseline metabolism, and adherence to diet changes significantly influence weight loss outcomes. Two patients on identical semaglutide doses may experience different results because of variations in how their bodies respond to GLP-1 receptor activation. Genetic factors affecting peptide pathways—such as the GLP1R, GIPR, FTO, and MC4R genes—influence appetite signaling, energy expenditure, and fat storage patterns.

Age, starting weight, physical activity level, and dietary consistency also shape your results. Patients who combine semaglutide with regular exercise and sustained calorie reduction typically achieve weight loss in the 15-22% range, while those with minimal lifestyle modification may see 5-10% loss. PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) maps 49 peptides across 14 metabolic pathways to reveal which genetic variations may affect your weight loss trajectory and medication response.

Dose Escalation and Progressive Weight Loss

Semaglutide dosing follows a gradual escalation schedule, starting at 0.25 mg weekly and increasing every four weeks until reaching an effective maintenance dose. This step-wise approach allows your body to adapt and helps minimize gastrointestinal side effects. Importantly, your dose may need to go up over time—but PlexusDx's pricing won't. Compounded Semaglutide Injection starts at $149 per month, flat across all doses and commitment tiers, so you never pay more if your doctor increases your dose.

Most patients reach their optimal dose—typically 1.7 to 2.4 mg weekly—by week 16. Weight loss accelerates as doses increase because higher concentrations activate GLP-1 receptors more broadly, amplifying satiety signals in the brain and slowing gastric emptying. Patients who plateau at a lower dose may still achieve 10-15% body weight reduction, which meaningfully reduces health risks for heart disease, type 2 diabetes, and metabolic syndrome.

Maintaining Weight Loss After Reaching Your Goal

Clinical data indicates that weight loss plateaus when semaglutide reaches steady-state in your system, usually between weeks 20 and 24. At this point, continued weight loss becomes slower and more gradual, though your new lower weight stabilizes because appetite suppression persists. Studies show that stopping semaglutide typically results in weight regain within one year—meaning long-term treatment maintains the health benefits you achieved.

PlexusDx serves all 50 states with compounded semaglutide from licensed 503A pharmacies, no insurance required and no membership fees. HSA and FSA accounts are eligible for payment, making ongoing treatment more affordable. Many patients view semaglutide as a long-term weight management tool rather than a temporary fix, similar to how blood pressure medications provide lasting benefit only while you take them.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose 100 pounds on semaglutide?

Patients starting significantly overweight (BMI 35+) have lost 100+ pounds when combining semaglutide with sustained lifestyle changes, though most lose 30-80 pounds. Your realistic loss depends on starting weight, genetic response, and commitment to diet consistency. PlexusDx's Precision Peptide Genetic Test can reveal whether your genetic profile predicts strong GLP-1 pathway responsiveness.

How quickly do you lose weight on semaglutide?

Most patients lose 1-2 pounds weekly during the first 8-12 weeks as their dose escalates, then 0.5-1 pound weekly as they approach maintenance dose. Rapid initial loss reflects both reduced calorie intake from appetite suppression and fluid shifts. After week 16, weight loss continues but at a slower, steadier pace until plateauing around week 20-24.

Is compounded semaglutide as effective as Wegovy?

Yes—when sourced from licensed 503A compounding pharmacies like those PlexusDx partners with. Compounded semaglutide contains the same active ingredient and achieves equivalent weight loss in clinical use. PlexusDx Compounded Semaglutide Injection starts at $149 per month, making it significantly more affordable than brand-name alternatives while delivering identical therapeutic effects.

What percentage of people lose significant weight on semaglutide?

Approximately 85-90% of people taking semaglutide lose at least 5% of body weight, and roughly 70% achieve 10% or greater body weight reduction. Only 10-15% experience minimal weight loss (<5%), typically due to genetic variation in GLP-1 receptor sensitivity or non-adherence to dosing schedules. Individual genetic profiles significantly influence these outcomes.

Does the Precision Peptide Genetic Test predict my weight loss?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) identifies genetic variants in GLP1R, GIPR, FTO, and MC4R that influence appetite, energy expenditure, and fat storage. While genetics don't determine your outcome alone, understanding your peptide-pathway profile helps personalize your treatment and set realistic expectations based on how your body is likely to respond.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.